ArticleClinical genitourinary cancer2022

Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity.

Juskaran Chadha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.